Pacific Biosciences Of California reported $-67786000 in EBITDA for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Accelerate Diagnostics AXDX:US -17170000 1.89M
Agilent A:US $ 514M 48M
Bruker BRKR:US $ 107.6M 17.5M
Danaher DHR:US $ 2757M 20M
General Electric GE:US $ 1770M 218M
Illumina ILMN:US $ 124M 151M
Myriad Genetics MYGN:US $ -4.8M 2.9M
Pacific Biosciences Of California PACB:US $ -67.79M 7.24M
Perkinelmer PKI:US $ 420.38M 11.6M
Thermo Fisher Scientific TMO:US $ 2861M 821M
Waters WAT:US $ 233.88M 5.74M